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SIFT-MS and FA-MS methods for ambient gas
phase analysis: developments and applications
in the UK
David Smith*a and Patrik Španěla,b
Selected ion ﬂow tube mass spectrometry, SIFT-MS, a relatively new gas/vapour phase analytical method,
is derived from the much earlier selected ion ﬂow tube, SIFT, used for the study of gas phase ion-mole-
cule reactions. Both the SIFT and SIFT-MS techniques were conceived and developed in the UK, the
former at Birmingham University, the latter at Keele University along with the complementary ﬂowing
afterglow mass spectrometry, FA-MS, technique. The focus of this short review is largely to describe the
origins, developments and, most importantly, the unique features of SIFT-MS as an analytical tool for
ambient analysis and to indicate its growing use to analyse humid air, especially exhaled breath, its unique
place as a on-line, real time analytical method and its growing use and applications as a non-invasive
diagnostic in clinical diagnosis and therapeutic monitoring, principally within several UK universities and
hospitals, and brieﬂy in the wider world. A few case studies are outlined that show the potential of
SIFT-MS and FA-MS in the detection and quantiﬁcation of metabolites in exhaled breath as a step towards
recognising pathophysiology indicative of disease and the presence of bacterial and fungal infection of
the airways and lungs. Particular cases include the detection of Pseudomonas aeruginosa infection of the
airways of patients with cystic ﬁbrosis (SIFT-MS) and the measurement of total body water in patients with
chronic kidney disease (FA-MS). The growing exploitation of SIFT-MS in other areas of research and com-
merce are brieﬂy listed to show the wide utility of this unique UK-developed analytical method, and
future prospects and developments are alluded to.
Introduction
Mass spectrometric analysis in its various forms has been
exploited for decades in biomedical research and is becoming
increasingly important in biochemical analyses and clinical
screening. Widely used techniques include gas chromato-
graphy mass spectrometry, GC-MS, which often uses pre-
concentration methods, and high performance liquid chrom-
atography mass spectrometry, HPLC-MS. More recently, elec-
trospray ionisation, ESI, coupled with tandem MS and matrix
assisted laser desorption ionisation, MALDI, usually combined
with high resolution time-of-flight, TOF-MS, is increasingly
being exploited. These powerful analytical methods are mostly
not useful for “ambient analysis”, i.e. direct real time analysis
of samples placed in air at atmospheric pressure, because they
usually involve sample preparation or extraction that delay ana-
lysis. Most importantly, these techniques are not accurately
quantitative without using external or internal standards.
Nevertheless, they have become essential in clinical medicine
when instantaneous targeted analysis is not a priority such as
for liquid phase analyses of blood, serum and urine and solid
phase analyses of biological samples (such as bacteria) de-
posited or placed on solid matrices.
Due to the early pioneering work of Linus Pauling using
GC-MS and subsequent work by many others, it is now known
that there is a large number of volatile organic compounds,
VOCs, in exhaled breath.1 Since Pauling’s suggestion that
these VOCs may open a non-invasive window to human
physiology and pathophysiology and, in principle, could be
exploited for clinical diagnosis, the science of breath analysis
has increasingly attracted the attention of analytical chemists
and clinicians. At this time of writing, there are many research
groups worldwide researching this topic, which prompted the
production of two research texts devoted to the topic of analy-
sis of trace VOCs in exhaled breath and in the vapour head-
space of biological fluids such as urine and mammalian and
bacterial cell cultures.2,3 Scrutiny of the published literature
reveals that the most widely used analytical method for breath
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analysis has been and remains GC-MS, but as stated above it
cannot be used for direct real time, accurately quantitative
ambient analysis of air, fluid headspace or exhaled breath.
Clearly, it is desirable to devise instrumentation by which
the trace metabolites present in single exhalations of breath
can be quantitatively analysed in real time at precision and
accuracy to be useful for clinical diagnosis. This was the goal
that the authors of this paper set themselves at Keele Univer-
sity UK in the year 1996, almost 20 years ago. Thus, focused
research and development over several years has realised the
analytical techniques called selected ion flow tube mass spec-
trometry, SIFT-MS, and flowing afterglow mass spectrometry,
FA-MS. Initial developments of these techniques were carried
out using very large, laboratory-based SIFT-MS instruments.
These have evolved to much smaller and readily transportable
instruments4 that are being exploited for real time ambient
analysis of exhaled breath and in other areas of research where
trace gas analysis is of value, such as environmental air analy-
sis and food science, and in important practical applications
exemplified by container air monitoring to detect illicit
materials and to protect the health and safety of customs
oﬃcials.5 SIFT-MS has been adopted in several research
laboratories worldwide, not least in the UK. In the spirit of a
themed collection of Analyst on analytical science in the UK,
this paper reviews the scientific and instrumental develop-
ments of SIFT-MS and FA-MS and its exploitation for various
research programmes in UK universities and research esta-
blishments (UK locations indicated in Fig. 1). The focus is
largely on their application to breath analysis and related
topics in physiology and medicine, but also mentioning other
areas of research in which these novel analytical techniques
are being exploited.
Breath analysis and the analytical
instrumentation required
As background to the instrumentation required to achieve real-
time quantitative breath analysis, it is instructive to state the
major objectives of breath research and analysis:
• Identify, quantify and recognize abnormal concentrations
of common volatile metabolites in the very humid air that is
exhaled breath.
• Diﬀerentiate between endogenous and exogenous volatile
breath compounds.
• Track changes in breath metabolite concentrations
accurately over short and long periods in support of
longitudinal studies, pharmacokinetics, and the eﬃcacy of
therapy.
• Identify new volatile biomarker compounds in breath
related to specific diseases and infections.
These requirements are common also to the many non-
volatile biomarkers present in other biological fluids that are
widely used in medical diagnosis. So what is a biomarker? A
widely accepted definition, used by the National Institute of
Health (NIH) is:6 ‘a characteristic that is objectively measured
and evaluated as an indicator of normal biological processes,
pathogenic processes, or pharmacologic responses to an inter-
vention.’ Example: the blood cholesterol level. The committee
defines ‘objectively’ to mean ‘reliably and accurately’. Thus,
the discovery of biomarkers in the form of reliable and accu-
rately measured concentrations of volatile compounds must
ultimately be a major objective of breath analysis research.
Therefore, in order to fulfil the requirement for objective
measurement, the most important, and indeed the most
challenging aspect of breath research is the development
of analytical methods that can realise positive identification
and accurate quantification of endogenous trace compounds
at appropriately low levels to be useful clinically as
biomarkers.
The demands on the desirable instrumentation are
increased when the objective is real time analysis of single
breath exhalations for which only a few seconds are available
for sample collection and analysis. This time constraint can
seriously diminish the analytical sensitivity, which can be
crucial when it is realised that many of the trace gas meta-
bolites and biomarkers are present in the very humid exhaled
breath at concentrations (partial pressures) of just a few parts-
per-billion by volume, ppbv, or lower. It is also essential to
minimise losses of trace metabolites (and water vapour; see
later) from the breath sample due to surface adsorption on
sample entry lines to the analytical reactor. However, if these
stringent conditions can be met, breath analysis can be carried
out non-invasively and quickly, obviating both sample collec-
tion and delayed oﬀ-line analysis that can compromise the
sample. As we will show in this review, these demanding
requirements have been met by SIFT-MS and so ambient analy-
sis of environmental air, exhaled breath and other humid air
samples can be accurately achieved in real time.
Fig. 1 Geographical locations of UK universities, hospitals and research
establishments that relate to the origins of SIFT, SIFT-MS and FA-MS
(yellow), their further developments and applications (blue) and the
current interdisciplinary collaborations (brown).
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It is clear that simply to identify unusual patterns of meta-
bolites in exhaled breath via the comparison and statistical
interpretation of multiple ion mass spectra or ion mobility pat-
terns obtained from the analysis of breath samples from
healthy and diseased persons circumventing positive identifi-
cation or adequate quantification of the trace compounds
involved, falls short of fulfilling the aforementioned criterion
for biomarkers. Although such data mining measures are
useful in the search for overall diﬀerences in breath compo-
sition, and they can oﬀer a basis for refocused research on
true biomarker identification, ultimately they are unlikely to
find use in clinical applications. Importantly, it must also be
forcibly stated that even when true biomarkers have apparently
been identified, their clinical value in diagnosis and their
benefit to the patients must be independently and objectively
tested and verified, preferably by multicentre studies. Even
though we have chosen to emphasise the interesting appli-
cation of ambient analysis to exhaled breath analysis, there are
wider applications where instant air analysis is becoming
increasingly valuable such as in environmental monitoring,
food science and health and safety practice. Brief references
will also be given to these applications in this short review.
Principles of the SIFT technique and
the SIFT-MS analytical method
To reiterate, a major object at the onset of this analytical
research was to realise a technique that could accurately and
simultaneously analyse in real time several of the trace volatile
compounds that are present in single exhalations of breath,
obviating sample collection prior to analysis, thus immediately
providing supporting diagnostic data to the attending physi-
cian in the clinical setting. As we will show, this has been
achieved with the latest SIFT-MS and FA-MS instruments.
In principle, direct analysis of air/breath can be achieved by
simply introducing a sample into a commonly used electron
ionisation, EI, ion source of a conventional mass spectrometer,
thus collectively ionising the trace constituents of the sample
along with the major air compounds (N2, O2, Ar, H2O, CO2),
immediately followed by analysis of the ion mixture by some
form of MS. However, the resulting mass spectra obtained by
this procedure are extremely complicated, comprising few
large product ion peaks originating from the major neutral
components and many minor peaks originating from the trace
compounds. Furthermore, there are multiple overlaps of these
product ions at several m/z (mass-to-charge ratio) values that
render identification and quantification of the original trace
compounds extremely diﬃcult, if not impossible. Not surpris-
ingly, this procedure has not been successfully used in breath
research.
To alleviate some of these intractable problems there have
been considerable innovations in analytical techniques,
especially in the use of compound separation in GC columns
prior to MS analysis,7,8 but the appreciable sample collection
and preparation times negate the real time requirement for
ambient analysis. So a major focus has been on “soft ionis-
ation” or “chemical ionisation”, CI, of analyte compounds
prior to MS analysis. This involves the selective ionisation of
the trace compounds in the sample using judiciously chosen
reagent cations (sometimes anions, but rarely) that do
not react at significant rates with the major air compounds
(N2, O2, H2O, Ar, CO2). Thus, CI circumvents the energetic elec-
tron collisions that result in molecular fragmentation and gen-
erates just one (or few) characteristic product ion(s) for each
neutral analyte, minimises product ion coincidences and
allows complex air mixtures to be analysed with considerably
less ambiguity. This is the ionisation method chosen by the
authors in the development of both SIFT-MS and FA-MS, fol-
lowing the expertise they acquired over many years in the
development and detailed application of the selected ion
flow tube, SIFT,9,10 and the flowing afterglow Langmuir
probe, FALP,11,12 techniques to the study of gas phase ionic
and electronic reactions.13
The SIFT technique
The SIFT technique, which is the basis of SIFT-MS, was con-
ceived and developed nearly 40 years ago in Birmingham Uni-
versity UK by N.G. Adams and D. Smith.10,14 It quickly became
a standard method for the study of ion-neutral reactions at
thermal interaction energies with its adoption in several labo-
ratories worldwide.15 Initially, it was developed to satisfy the
need for the great deal of kinetic data on gas phase ion-neutral
reactions that are required to describe the production of the
molecules observed in cold interstellar clouds.13 However, its
use quickly extended to the studies of the ionic reactions rele-
vant to other media, notably the ionised terrestrial atmos-
phere,16,17 studies of which have a direct bearing on the
development of SIFT-MS, as will see later. Thousands of ion-
neutral reactions have been studied using the SIFT technique
in several laboratories around the world, not least in the UK
(see ref. 10, 13 and 18–20 and the references therein). This has
resulted in a large kinetics database, a better understanding of
the fundamental aspects of ion-neutral reactions, and an
appreciation of the ion chemistries occurring in naturally
ionised media.17 Some of these early kinetics data are adding
to the kinetics library needed for SIFT-MS analyses, as will be
mentioned later.21–23
The principle of the SIFT technique is as follows. Mixtures
of positive ions, electrons and negative ions are created in a
gas discharge ion source and from this plasma mixture a
current of ions of a chosen mass-to-charge ratio, m/z, is
obtained using a quadrupole mass filter.10,24,25 These precur-
sor ions (cations or anions) are injected into a fast-flowing
inert carrier gas (usually pure helium at a pressure of typically
100 Pa (about 1 Torr)) through a Venturi-type inlet.10,14,21,26
Thus, a cold precursor ion/helium gas swarm is created pos-
sessing a Maxwellian speed distribution appropriate to the
temperature of the helium carrier gas (usually 300 K, but can
range from 80 K to 600 K in more sophisticated instru-
ments24,27). This swarm is convected along the flow tube and
the ions are sampled downstream via a pinhole orifice and
Analyst Critical Review
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focused into a diﬀerentially pumped quadrupole MS.4,26 After
m/z analysis they are detected and counted by an electron mul-
tiplier/pulse counting system.
To determine the rate coeﬃcient, k, and ion products of the
chosen injected ions with the molecules of a reactant gas, a
controlled and measured flow rate of the reactant gas is intro-
duced into the helium carrier gas and the count rates of the
precursor ions (reducing) and the product ions (increasing) are
measured by a downstream MS/detection system. A simple
analysis of the count rate of the precursor ions as a function of
the reactant gas flow rate provides the k for the reaction. There
is more than one product ion generated in most ion-molecule
reactions; analysis of the count rates of the product ions pro-
vides the percentage product ion distribution. Many ion-mole-
cule reaction processes that occur in ionised media have been
recognised and investigated by extensive SIFT studies involving
many types of organic molecules, formerly at Birmingham Uni-
versity, latterly at both Keele University and the J. Heyrovsky
Institute in Prague, and in other laboratories over the
years.15,21 Much of the essential kinetics data needed for wide-
ranging SIFT-MS analyses have been obtained by these studies,
as will be shown later.
The SIFT-MS analytical method
The essence of the SIFT-MS analytical method is as follows. If
the rate coeﬃcient, k, is known for the reaction of a particular
precursor ion (now the reagent ion) with reactant molecule, M,
(now the analyte molecule) then, in principle, the decrease in
the reagent ion count rate, I, (as monitored by the downstream
MS) as analyte molecules, M, flow into the carrier gas can be
used to determine [M], the number density of M in the helium
carrier gas of the SIFT-MS instrument. However, if a sample of
gas (such as exhaled breath) containing many diﬀerent trace
gases is introduced simultaneously into the carrier gas, then
the reduction in I will reflect the net eﬀect of the reactions of
all the individual analyte gases, so discriminant analysis of the
mixture will not be achieved by recording I only. Furthermore,
for trace gas analysis, the fractional reduction in I is, by neces-
sity, very small28 and therefore measurement accuracy
would be poor. But if the reactions of each M with the reagent
ions result in characteristic product ions at a known m/z,
the measured signal levels of these characteristic ions,
even though very small, will both identify and allow the indi-
vidual trace compounds M in the mixture to be quantified to
good accuracy and precision.4,21,29–31 This then is the principle
of SIFT-MS analysis. The actual procedure to obtain the raw
data on reagent/product ion count rates is briefly alluded to
later.
A simple example of this analytical ion chemistry is the
reaction between the most commonly used reagent ion H3O
+
(see below) and analyte molecules, M, which generally pro-
ceeds via proton transfer:
H3Oþ þM ! MHþ þH2O ð1Þ
It is simple to show that the number density of the charac-
teristic product ions [MH+]t is related to the number density of
the reagent ions [H3O
+] thus:
½MHþt ¼ ½H3Oþk½MtDe ð2Þ
k is the rate coeﬃcient for the reaction and t is the reaction
time. De is a diﬀerential diﬀusion enhancement coeﬃcient
that accounts for the fact that the reagent ions and the
product ions diﬀuse through the helium carrier gas to the
walls of the SIFT-MS flow tube at diﬀerent rates. This pheno-
menon influences the relative number densities of the reagent
and product ions arriving at the downstream ion sampling
orifice (see Fig. 2) and, consequently, their count rates as
determined by the downstream analytical MS/detection
system. This phenomenon, and also mass discrimination
against larger m/z ions that usually occurs in the analytical
quadrupole mass spectrometer, must be accounted for to
obtain accurate quantitative analyses.26,32–34 It is interesting,
and to some degree corrective, that diﬀerential diﬀusion
enhances the count rates of the heavier ions and mass dis-
crimination diminishes their count rates. Thorough
studies26,34 of these opposing eﬀects have resulted in the
formulation of a sophisticated algorithm by which absolute
analyte concentrations in air are obtained.32 This algorithm
contains as the primary measured parameter the ratio of the
total product ion count rate to the total reagent ion count rate
(including both hydrated reagent and product ions; see below).
Note that if any drift/variation occurs in the reagent ion count
rate due to discharge plasma source variations, these changes
are reflected directly in the product ion count rates and so the
analysis is not compromised. Thus, the accurate measure-
ments of reagent and characteristic product ion count rates by
the downstream mass spectrometer detection system provide
real-time quantifications of trace gases in complex mixtures
such as polluted air and exhaled breath.
A very important point to appreciate is that only a few
reagent ion species are suitable for SIFT-MS analyses of air
and breath. It turns out that H3O
+, NO+ and O2
+ are most suit-
able, because these ions do not react rapidly with the major
components of air and breath viz. N2, O2, H2O, CO2 and Ar;
this was revealed by previous detailed SIFT studies, many in
the UK, of the ion chemistry relating to the terrestrial atmos-
phere.17 For SIFT-MS, detailed knowledge is required of the
kinetics of the ion-molecule reaction processes occurring
when H3O
+, NO+ and O2
+ reagent ions react with the wide
variety of organic molecules that are present in biogenic
samples. Without this knowledge, the recognition of compo-
site trace components of complex matrices such as exhaled
breath and the accurate quantification of the individual com-
pounds cannot be achieved. This knowledge has been acquired
by numerous studies, mostly in Keele and Prague, of the
reactions of these three reagent ions with many volatile
organic compounds, VOCs, including homologous series of
alcohols, aldehydes, ketones and other compounds, as listed
in Table 1. It turns out that there are trends in reactivity that,
Critical Review Analyst
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when recognised, greatly facilitate identification of unknown
trace compounds in SIFT-MS analyses.
The reactions of H3O
+ reagent ions are sometimes relatively
simple, proton transfer producing MH+ nascent ions as indi-
cated by reaction (1). However, often the nascent MH+ ions
partially fragment with the loss of an H2O molecule, as seen in
Table 1. In a sense conversely, the SIFT-MS spectra reveal that
hydration of both H3O
+ reagent ions and MH+ product ions is
very common when breath samples are being analysed (see
below). The reactions of NO+ reagent ions are varied with
Table 1 Processes that occur in the bimolecular and termolecular reactions of H3O
+ and NO+ ions with various classes of organic compounds
Compounds H3O
+ reactionsa NO+ reactionsa
Alcohols35 MH+; (M–OH)+ (M–H)+; (M–OH)+
Diols36 MH+; (M–OH)+ (M–H)+; (M–OH)+
Ketones37,38 MH+ NO+M; M+•
Saturated aldehydes38,39 MH+; (M–OH)+ (M–H)+
Unsaturated aldehydes38,39 MH+ (M–H)+; NO+M
Carboxylic acids40 MH+; (M–OH)+ NO+M; (M–OH)+
Esters40 MH+; (M–OR)+ NO+M; (M–OR)+
Ethers41 MH+; (M–OR)+; (M–R)+ (M–H)+
Organosulphur42 MH+ M+•
Amines43,44 MH+; (M–H)+; (M–R)+ M+•; (M–H)+; (M–R)+
Alkanes45,46 H3O
+M (M–H)+
Alkenes45,46 MH+ M+
Monoterpenes47,48 MH+, (M–R)+ M+•; (M–R)+
Aliphatic halocarbons49,50 MH+, H3O
+M, (M–X)+, (M–X)OH+ (M–X)+; M+•; NO+M
Aromatic hydrocarbons45,46 MH+ M+•
Aromatic halocarbons49,50 MH+; (M–X)+ (M–X)+; M+•; NO+M
Phenols51 MH+ M+•
H2S,
52 HCN,53 NH3
54 MH+ —
a The reactant molecules are designated as M, protonated molecules as MH+ and parent radical cations as M+•. NO+M and H3O
+M are adduct
ions formed largely in ternary association reactions.21,55 Product ions resulting from the loss of neutral fragments are indicated by bracketing,
for example (M–OH)+ indicates the loss of OH from the nascent ion; the R are alkyl radicals; the X are halogen atoms, either Cl or Br. Note that
NO+ is unreactive with CH3OH, H2S, HCN and NH3.
Fig. 2 A schematic diagram of the Proﬁle 3 SIFT-MS instrument showing the microwave discharge ion source, injection mass ﬁlter and the three
metal discs to which ion current can be measured and which support the oriﬁces through which (i) ions pass from the ion source into the injection
mass ﬁlter, (ii) mass selected reagent ions enter the ﬂow tube reactor, (iii) reagent and product ions pass from the carrier gas/reactor into the analyti-
cal quadrupole mass spectrometer. Both direct sampling of ambient air and exhaled breath into the instrument and sampling of breath collected
into bags and of liquid headspace can be achieved. Reproduced with permission from RSC from ref. 28.
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hydride ion transfer producing (M–H)+ ions, hydroxide ion
transfer producing (M–OH)+ ions and adduct ion formation
producing NO+M ions being commonly observed. The reac-
tions of O2
+ reagent ions initially proceed via electron transfer
generating M+• radical parent cations that usually fragment
when M is polyatomic. To repeat, the understanding of and
the kinetics data relating to these reaction processes is essen-
tial for the interpretation of SIFT-MS analytical spectra and is
especially important for researchers developing and expanding
the SIFT-MS analytical method. However, such expertise is not
essential for scientific, clinical or technical personnel who are
focused on routine analysis, since it is implicitly contained
within the on-board kinetics library, the construction and
structure of which is described and explained in recent
papers.29,56 Much has been written on the details of the above
analytical ion-molecule reaction processes in many research
and review papers.13,17,21,57
A complicating eﬀect, alluded to above, becomes obvious
when using SIFT-MS to analyse humid samples, which is the
appearance on the analytical spectra of hydrated reagent ions,
especially H3O
+(H2O)1,2,3 and NO
+(H2O)1,2 cluster ions. These
cluster ions are formed largely by helium-mediated three-body
association reactions of the H3O
+ and NO+ reagent ions with
the abundant H2O molecules present in humid samples. A
further complication is that the product ions can also become
hydrated resulting in ions like MH+(H2O)1,2 and (M–
H)+(H2O)1,2 and these hydrated ions must be considered as
additional reagent and product ions and properly accounted
for in the quantitative analysis of individual trace compounds.
This phenomenon is accounted for in the more sophisticated
SIFT-MS analysis described in two detailed publications32,58
that describe how accurate SIFT-MS analyses are obtained.
This aspect and other interesting and unique features of
SIFT-MS are discussed in detail in several research and review
papers.4,21,28,29,59 A major issue complicating routine use of
SIFT-MS for analyses of biological samples is the overlap of
product ions resulting from diﬀerent compounds at the same
m/z values. Whilst this has been overcome in individual cases
either by using the most appropriate reagent ions for each
analyte compound or by utilising diﬀerences in product
ion signal ratios,56,60 these approaches are a challenge for non-
chemists and there is a need for more developments of robust
and simpler data analysis procedures.
SIFT-MS instrumentation
All generations of SIFT-MS instrument have essentially the
same form. They consist of an ion source and ion selection
(injection) quadrupole mass filter, a carrier gas flow tube
reactor, a downstream analytical quadrupole mass spectro-
meter, a drive pump for the carrier gas and turbo pumps to
maintain the quadrupole chambers at suitably low pressures.
The size, cost and performance of the instrument largely
depends on the performance of the quadrupoles, the length
and diameter of the flow tube, the pumping speeds of the
carrier gas drive pump and the turbo pumps, and the nature
of the ion source. The ultimate sensitivity of the instrument as
an analytical device depends on the achievable reagent ion
count rates and consequently the product ion count rates, but
these are also dependent on the choice of the of interdepen-
dent parameters such as the carrier gas and sample gas flow
rates and the ion sampling orifice aperture sizes. Fig. 2 shows
a schematic of Profile 3 SIFT-MS instrument that was develo-
ped and marketed in the UK.4,26 The detailed considerations
of the analytical sensitivity and all the dependent parameters
and variable are discussed in recent papers, especially the
review paper.4 The limit of detection of the Profile 3 instru-
ment is currently at 0.1 parts-per-billion by volume, ppbv, for
one second of integration time of the product ions count rates,
but this is being improved continuously with the expectation
of an order-of-magnitude improvement as the engineering
aspects of SIFT-MS instrumentation and understanding of the
associated physics and ion chemistry grows. However, by low-
ering the limit of detection the chance of significant overlap of
analyte ions at the same m/z with fragment ions of other com-
pounds in the matrix or background air increases and this will
have to be considered in future developments of advanced
SIFT-MS instruments. It is self-evident that a desirable goal is
to produce small, low cost instruments with improved per-
formance that can readily be moved and utilized in diﬀerent
locations. Remarkable strides have been made towards these
objectives, notably in the UK, by reducing the size of the initial
laboratory-based instruments, initially at about 2000 kg, to the
production of the much smaller, portable Profile 3 instrument
at 120 kg.4 This has required that the reactor flow tube length
was shortened from about 140 cm down to 5 cm.
The current SIFT-MS instrument
The performance of the UK Profile 3 SIFT-MS instruments and
the quality of trace gas analyses obtained in a variety of appli-
cations in the UK are illustrated by the data presented in
several research and review papers by the teams at
Keele,29,61–66 Prague,67–73 Thunder Bay, Canada,74–77 Imperial
College London78–90 and the University of The West of
England.91,92 Major application have been in physiology
and medicine through the analyses of exhaled breath and the
headspace of biological fluids such as urine and mammalian
and bacterial cell cultures, ultimately intended as a contri-
bution to clinical diagnosis and therapeutic monitoring. Other
areas of applications of Profile 3 include environmental
science, food science and analyses of fumes of explosives as
summarised in Table 2 later together with appropriate
references.
SIFT-MS as a trace gas ambient analytical technique was
initially conceived and developed at Keele by the authors of
this paper9,30,93 benefiting from the earlier development of the
SIFT technique by the Birmingham group,10,14 subsequently
with significant contribution by the Aberystwyth group.94,95
The growing use and application of SIFT-MS in the UK is seen
in the geographical distribution of the groups who are now
benefiting from the exploitation of this analytical method seen
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in Fig. 1. The Profile 3 is its latest manifestation and it is this
instrument that is the focus of this paper by illustrating its
unique power in directly analysing the humid media men-
tioned above. When the volatile compounds emitted by such
humid media can be analysed accurately in real time at appro-
priately low concentration, then analyses of less humid
ambient air are relatively straightforward.
Other models of SIFT-MS instruments have been produced
in New Zealand and marketed by the Syft Company as the
Voice 100/200 instruments.159,168 These have also been used
for breath analysis,169–172 monitoring of environmental
pollutants,157–160 warfare agents studies173 and in food
science.140–152,174 The main commercial application of Voice
200 instruments is in screening of containers in ports for
illicit substances and for toxic gases in order to protect the
health and safety of customs oﬃcials.5,164
Quantitative analyses by SIFT-MS
The analysis by SIFT-MS of trace gases in air invariably begins
by obtaining a so-called full scan (FS) spectrum in which one
of the reagent ion species (H3O
+, NO+, O2
+) is selected and
injected into the helium carrier gas and the air is sampled
into the thermalized ion swarm at an acceptable flow rate.
This usually results in a complex FS spectrum of reagent and
product ions that can both identify and allow the quantifi-
cation of the neutral trace compounds in the sample. Sample
FS spectra are shown in Fig. 3 that were obtained for the analy-
sis of the humid headspace of a fungal culture175 using sepa-
rately H3O
+, NO+ and O2
+ reagent ions. The challenge is then
to identify the trace neutral compounds present in the sample
via their characteristic product ions at particular m/z values.
Commonly met product ions are easily recognised if their
Table 2 Areas of application SIFT-MS
Biomedical
Physiology
Breath Influence of diet on breath volatiles69,96–98
Ethanol metabolism99–101
Oral microflora and diﬀerence between nasal and oral exhalations102,103
Exercise103,104
Urine Ketones in urine105,106
Volatile markers of ovulation in urine107,108
Skin Release of volatile compounds by skin109
Halitosis
Odorous breath compounds61
Addiction and substance abuse
Breath composition after antabuse ingestion110
Compounds in tobacco and cannabis smoke9,111,112
Renal failure
Breath biomarkers of kidney dysfunction54,113–115
Total body water monitoring116–119
Bacterial infection
Breath biomarkers of infection in cystic fibrosis120–124
Alveolar lavage125
Bacterial cultures61,126,127
Cancer
Breath Diagnostic breath biomarkers128,129
Tissue cell cultures
Volatile compounds released by cancer cell lines130,131
Urine Volatile biomarkers of cancer and infection in urine132,133
Diabetes
Breath biomarkers134–136
Inflammatory bowel disease
Breath biomarkers of disease activity68
Food science
Quantification of aroma compounds in fermentation137
Oil quality138,139
Food flavour analyses137,140–153
Volatile compounds emitted by fruits and vegetables140
Volatile organic compounds related to sensory qualities140
Environment; health and safety
Biological monitoring154
Exhaust gases155,156
Atmospheric pollutants157–163
Monitoring of cargo containers164
Security
Detection of volatile markers of explosives165–167
Fumes of explosions166
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signal levels are suﬃciently high and then a quick quantitative
analysis of the neutral analyte trace molecules can be obtained
by exploiting the SIFT-MS kinetics library; some such common
compounds are shown on the spectra in Fig. 3. For product ion
at low signal levels, multiple FS spectra can be accumulated to
facilitate analysis and improve precision. Some ions cannot
readily be recognised and then, as a first stage in the analysis,
ion-chemical intuition is needed that can be acquired by study-
ing the extensive kinetics data accumulated on ion-molecule
reactions that is reported and discussed in many SIFT-MS-related
papers.35,36,38–40,42–47,49–51,56,176–184 Comparing FS spectra for
all three reagent ions provides assistance in recognising the
unknown neutral compounds in the air mixture given the
diﬀerent ion chemistries involved. Significantly, these spectral
data are obtained rapidly in real time avoiding the likely disturb-
ing eﬀects that can result from sample collection and manipu-
lation. Numerous such studies have been carried out that are
providing much data of interest in the biological and environ-
mental sciences.35,36,38–40,42–47,49–51,56,176–184
When the m/z values of characteristic product ions are
recognised in the FS spectrum, more accurate analysis of the
trace neutral compounds is achieved using the multiple ion
monitoring (MIM) mode of SIFT-MS. In this approach, the m/z
values of all the reagent and characteristic product ions for
each trace compound are entered into the analytical software
and a rapid switch/dwell/count procedure for each of the ions
is used to accumulate the reagent ion/product ion signal count
rates that provide the trace neutral compounds quantifi-
cations. This procedure can be very rapid, which allows tem-
poral changes in the concentrations of trace compounds to be
followed in real time, a good example being the definition of
the concentration profiles of several exhaled breath com-
pounds simultaneously obtained from consecutive single
breath exhalation/inhalation cycles, as seen in Fig. 4, which
shows the reproducibility of the data acquired by on-line, real
time SIFT-MS analyses of single breath exhalations. They also
show the very wide range of compound concentrations that is
accessible in single exhalations from those for water vapour
Fig. 3 .SIFT-MS full scan mass spectra (ion mass-to-charge ratio, m/z, plotted against the ion counts-per-second, c/s) showing the compounds
present in the headspace of A. fumigatus (AF) cultures when analysed employing H3O
+ (A), NO+ (B) and O2
+• (C) as the reagent ion. The cultures
were incubated at 37 °C for 72 h prior to the headspace analysis. The product ions of the trace compounds produced by AF are indicated as ﬁlled
bars on the mass spectra. Note that small fractions of the hydronium ion and its hydrates (H3O
+)0,1,2,3 at m/z 19, 37, 55, 73 are also present in the
NO+ and O2
+• spectra (B and C respectively), which are shown with open bars. Reproduced with permission from RSC from ref. 175.
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(a unique feature of SIFT-MS185) and carbon dioxide,186 both
at the few percent level, to the trace compounds acetone and
hydrogen cyanide at the few ppbv level. Ipso facto, temporal
variations in the concentrations of specific trace compounds
can be followed exemplified by the breath concentration decay
curves of ethanol and its metabolite acetaldehyde shown in
Fig. 5. These well-defined decay curves were obtained by ana-
lysing exhaled breath every minute or so for a period of about
3 hours following the ingestion by an individual of a small
amount of ethanol.99 Clearly, on-line real time analysis is very
acceptable in the clinical environment, since it is a simple,
non-invasive procedure, the data being immediately available
to the clinician/health worker. Similarly, the temporal changes
in the concentrations of particular volatile biomarker com-
pounds in exhaled breath have applications in pharmaco-
kinetics and the tracking of drug-related compounds in the
therapy clinic.
Many related studies imping on physiology and medicine
have been carried out using Profile 3 instruments, principally
in the UK, Czech Republic and Canada. They include the
modification of breath biomarkers due to dietary intake69,96
and exercising,103 headspace analyses of several mam-
malian128,130,131,187and bacterial cell cultures64,126,188,189 and
fungal175 cultures, and volatile compounds released from
urine sampled during ovulation,107,108 just to mention a few;
refer to Table 2 for further applications and references. It is
not appropriate to attempt to discuss many of these studies in
detail in this short review; rather, a few case reports will be
given in the penultimate section of this paper that demon-
strate the special value of SIFT-MS for ambient gas analysis.
Principle of the ﬂowing afterglow
mass spectrometry, FA-MS, analytical
method
A SIFT-MS FS spectrum obtained using H3O
+ reagent ions
when humid air or exhaled breath is introduced into the
helium carrier gas immediately reveals the appearance of
H3O
+(H2O)1,2,3 hydrate cluster ions as major fraction of the
total ions (see Fig. 3a for instance). Further to this, the 2H
(deuterium, D), 17O and 18O isotopologue variants of these
cluster ions are present (more clearly seen in Fig. 6a for
D-enriched water), the peak relative levels of these isotopolo-
gues are determined by the fractions of each isotopic variant
of the water molecules (H2O, HDO, H2
17O, H2
18O) comprising
the water vapour introduced into the system. The natural
abundances of these isotopic variants in local water are known
and the distribution of the isotopologue cluster ions is seen to
be in accordance with these abundances.119,190,191
These FS observations immediately suggested that the iso-
topic content of water vapour, especially that of the most abun-
dant HDO, might be determined quickly and directly from the
relative peak heights of the isotopologue ions, avoiding
complex sample preparation that is used in conventional
methods for deuterium isotope analysis.192 Encouragingly,
pilot experiments at Keele using known admixtures of heavy
water, D2O, in water, H2O, showed that the HDO content of the
water vapour above the enriched liquid could be determined
with precision and accuracy when the ion chemistry and
physics of isotope exchange in the relevant ion-molecule reac-
tions is understood, as is outlined below.193 This provided the
opportunity to study in real time the deuterium content of the
Fig. 4 Plots of the time proﬁles and the derived breath concentrations
of water vapour and CO2 (in %) and acetone and HCN (in parts-per-
billion by volume, ppb), obtained using the Proﬁle 3 SIFT-MS instrument
in the multi ion monitoring, MIM, mode, for six sequential breath exhala-
tions by one volunteer during the time period indicated in seconds.
These data show the remarkable consistency in the derived concen-
trations of these compounds in the alveolar regions of the exhalations,
as indicated by the shaded portions. Also indicated to the right are the
laboratory air levels of these compounds. Reproduced from ref. 28, with
permission from RSC.
Fig. 5 The variation of the concentration of ethanol and its metabolite
acetaldehyde, and the endogenous acetone (in parts-per-billion by
volume, ppb) in mouth-exhaled breath as a function of time following
the ingestion by a healthy volunteer of 7.5 mL of ethanol dissolved in
250 mL of water. Also given is the exponential time constant (τ, in min)
for the exhaled ethanol concentration as obtained from the slope of the
semi-log plot. Reproduced from ref. 99 with permission form Wiley.
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water present in biological fluids, including exhaled breath
and urine.
The physical and ion chemical principles underpinning
this novel analytical method are as follows: a swarm of H3O
+
precursor ions is created in the helium carrier of the SIFT-MS
instrument by ion injection in the usual way. The water vapour
evolving from natural water or D-enriched water (or that
present in exhaled breath) is sampled into the carrier gas
where the H3O
+ precursor ions react with the H2O, HDO,
H2
17O and H2
18O molecules in the water vapour sample. The
signal levels of D-containing isotopologues associated with the
H3O
+(H2O)0,1,2,3 ions are all enhanced when D-enriched water
vapour is the sample (see Fig. 6a). Of special interest, for the
thermodynamic reasons explained in detail in a previous pub-
lication,193 is the trihydrate ion, H3O
+(H2O)3 at m/z = 73, and
its isotopic variants H8DO4
+ and H9
17OO3
+ at m/z = 74 and
H9
18OO3
+ at m/z = 75. The isotopic abundance of 17O (typically
0.0380) and 18O (typically 0.200) in local water are known.
Thus, by using the signal level of H9
18OO3
+ at m/z = 75 as a
reference, the fraction of the isotopologue ions H9
17OO3
+ to
the total ion signal at m/z = 74 can be calculated and adjusted;
then a measurement of the m/z 74/75 ion signal ratio using the
downstream mass spectrometer provides the fractional deuter-
ium abundance in the water vapour sample.194 Correction is
made for the diﬀerences in evaporation rates of H2O and HDO
from the liquid water samples that, of course, depend on the
water temperature; in the case of breath analysis, the tempera-
ture at the lung blood/breath interface (body core temperature)
is taken. This new method of D quantification (assay)
was proven by careful experiments using standard mixtures of
D-enriched water.190
Of particular interest in renal medicine and body compo-
sition, as explained by the local nephrology consultant at the
University Hospital of North Staﬀordshire (S. J. Davies), is the
rapid measurement of total body water, TBW, especially in
patients suﬀering from chronic kidney disease who suﬀer
from serious water overload. The standard method of measur-
ing TBW is the isotopic dilution method. This involves the
ingestion of a known (small) amount of D2O, which rapidly
converts to HDO in the large H2O water pool in the body, and
the subsequent analysis of the equilibrium HDO content of
blood and/or urine. The main reason why this very safe
method is not used more frequently is the time consuming
and complex method of measuring D enrichment of the body
fluids,192 which usually requires that batch samples are sent to
reference laboratories for analysis consequently involving
delays in obtaining results. Thus, following the above encoura-
ging laboratory SIFT-MS studies, pilot experiments were con-
ducted to measure TBW in several healthy volunteers using
the isotope dilution method and the rapid, on-line direct
SIFT-MS analysis of the D content of the water vapour
contained in single breath exhalations.
These pilot measurements were carried out using an early
version of SIFT-MS and demonstrated the eﬃcacy of this
analytical method.119,191,195,196 This oﬀered the tantalizing pro-
spect of immediate non-invasive measurement of TBW at the
bedside and, alternatively, the measurement of the deuterium
content of the equilibrated headspace above a body fluid such
as plasma that can be collected and stored in a sealed con-
tainer for later oﬀ-line analysis. However, the use of the early
SIFT-MS instrument provided data that was not at the desir-
able accuracy and precision for serious clinical work except by
adopting multiple measurement procedures. To achieve the
required accuracy and precision a novel type of ion flow tube
device was developed termed flowing afterglow mass spec-
trometry (FA-MS). This is a simpler instrument that is dedi-
cated only to the measurement of the HDO content of water
vapour, unlike the more versatile SIFT-MS instruments. The
FA-MS instrument is smaller and more readily portable. It dis-
penses with the upstream mass filter of the SIFT-MS (see
Fig. 2) and the H3O
+ precursor ions are created directly by a
weak microwave discharge through the flowing helium/moist
air mixture. This results in much larger count rates of the
Fig. 6 (a) The SIFT-MS mass spectrum (counts per second, c/s against
ion mass-to-charge ratio, m/z) obtained as the water vapour from D2O
−
enriched water is ﬂowed into the helium carrier gas. The observed
isotopologues of the trihydrate of H3O
+ are indicated in the inset.
Reproduced with permission from ACS from ref. 194. (b) Determination
of body water deuterium abundance, R1liq, expressed in parts per million
(ppm) of hydrogen obtained from single breath exhalations, and the
derived total body water, TBW, in litres (L) obtained from the equilibrium
value of R1liq some 2 h following the ingestion of 27 mL of D2O. The
open squares refer to the control volunteer (no D2O ingestion) and the
ﬁlled squares to the breath of the volunteer (body weight 92 kg) both
before and after the ingestion of the D2O (at time zero). Reproduced
with permission from Wiley from ref. 191.
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analytical H3O
+(H2O)3 ions and its isotopic variants that, via
statistics, immediately increases the accuracy and precision of
the measurement of the HDO content of the water sample.
These important considerations have been thoroughly dis-
cussed in previous papers.190,194
An example of the raw data describing the time evolution of
the D content of exhaled breath following D2O ingestion is
shown in Fig. 6b with explanatory notes in the caption. With
FA-MS the HDO/H2O molecule ratio in single breath exhala-
tions and urine/blood headspace aspirations can be obtained
to about 1% precision and accuracy.190 Thus, when this ratio
is measured following the ingestion of an accurate mount of
D2O, typically 0.3 ml kg
−1 body weight, the TBW value can be
determined to an accuracy of a few hundred mL in most cases,
which is adequate for most clinical purposes. One of the
advantages of this method is that multiple samples can be
taken in rapid succession enabling the determination of the
kinetics of HDO equilibration throughout the TBW (Fig. 6b).
Typically, it is found that full equilibration occurs within
90 minutes within the TBW following oral ingestion of D2O.
119
In a series of clinical studies undertaken to establish the
validity of the above analytical method, it was shown that
measurement of TBW is both feasible and acceptable to
patients attending the dialysis clinic.117,197 These cited refer-
ences indicate the great potential of FA-MS in determining
TBW of healthy persons and ill-patients alike. Further studies
are currently in progress to establish the value of the FA-MS
approach to monitoring body composition and to support
intervention to minimise the complications of water overload
in dialysis patients. It is now envisaged that optical absorption
spectroscopy could be used to develop miniature point-of-care
instruments for isotopic analyses of water vapour in exhaled
breath.
Brief reports on selected research
programmes involving SIFT-MS
The creation of this powerful ambient analysis technique pro-
vided the means to promote the wide variety of research areas
listed in Table 2, the results of which are detailed in the cited
references. Here, just a few topics are selected for brief review
that illustrate the unique contribution that the exploitation of
SIFT-MS is making to physiology and medicine via detailed
breath analysis and associated studies of volatile compounds
released by in vitro cultures of mammalian and bacterial cells.
The focus is on the work carried out by research groups in the
UK in collaboration with the closely associated group in
Prague using the SIFT-MS instruments developed and manu-
factured entirely in the UK. Before starting, it is pertinent to
note that analytical studies involving the wide range of volatile
compounds released from biological fluids could not be
pursued without parallel and continuing experiments to
accumulate the large amount of kinetics data on ion-molecule
reactions that are essential to build the aforementioned kine-
tics library for SIFT-MS. The results of these kinetics studies
are reported in several research papers, as summarised in
some recent reviews.4,28 Such work must be seen as integral
part of the time and intellectual eﬀort that has been required
to develop the SIFT-MS and FA-MS analytical methods.
Breath analysis involving healthy volunteers
Breath analysis is a relatively new area of experimental science
and physiology and medicine. When the SIFT-MS analytical
method was proved to be accurately quantitative and the sim-
plicity of its application to breath analysis was demonstrated, a
programme was initiated to study the reference ranges (popu-
lation concentration distributions) of the common metabolites
in exhaled breath of the healthy population. This is an essen-
tial prelude to studies of abnormal concentrations of meta-
bolites in exhaled breath of patients with specific disease or
infections. Data acquisition of the kind illustrated in Fig. 4 can
be rapid and the exhaled breath of as many as 70 volunteers
has been analysed for several metabolites in a single
morning.72 The breath of healthy cohorts can be analysed over
periods of days or months and by such longitudinal (inter-
individual variations) studies the reference ranges of several
common breath metabolites have been constructed by work at
Keele, Prague and the Silsoe Research Institute (C. Turner) in
the UK.198–202 Examples of the data obtained are shown in
Fig. 7 (reproduced from ref. 203); these are immensely valuable
as guides to subsequent studies. Similarly, variations in breath
metabolite concentrations within given persons (intra-indivi-
dual variations) have been carried out,204 which reveal temporal
and diurnal variations and the influence of diet, the last being
dramatically revealed by the study of breath acetone following
a ketogenic diet.69
Another important phenomenon, so significant in breath
research, is the recognition that mouth-exhaled breath can be
seriously contaminated with the volatile compounds generated
in the oral cavity by the action of bacteria or salivary
enzymes.102,103 To reveal which compounds are orally gener-
ated, the simplicity of real-time breath analysis by SIFT-MS is
again exploited by directly analysing separately the breath
exhaled via the nose and mouth. Such studies immediately
reveal, for example, that ammonia and ethanol are largely pro-
duced in the oral cavity whereas acetone and isoprene are
purely generated systemically.61,63 Breath analysis research
exploiting SIFT-MS vigorously continues in the UK; this
includes studies at the Open University (C. Turner)205–209 of
the exhaled breath of cattle210 and horses with colic211 and
concomitant breath and skin analysis for monitoring blood
glucose concentration in diabetes,212,213 and interesting inves-
tigations at Nottingham University of the relation between
exhaled breath and blood levels of volatile compounds,
notably acetone.170 Also the Voice 200 instruments are increas-
ingly becoming used for breath analysis.169,171,172,214
Volatile compounds emitted by in vitro cultures of
mammalian and bacterial cells
The hope and expectation for many years has been that volatile
compounds released by living cells cultivated in vitro, for
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example malignant human cell cultures and bacterial cultures,
will assist and direct the search for in vivo biomarkers of
disease or infection via breath analysis. This is an on-going
search that has yet to be rewarded to the degree that satisfies
practising clinicians, except for important developments in
respiratory bacterial infection, as briefly described later. The
first SIFT-MS studies investigated volatile compounds emitted
by the cancer cell lies CALU-1 and SKMES that revealed the
emission of easily measurable amounts of acetaldehyde the
release rate correlating well with cell numbers in the cul-
tures.131 These results seemed to suggest that this aldehyde
might be a biomarker in exhaled breath of lung tumours.
However, this hope was soon dispatched by the discovery that
some other malignant and non-malignant cells cultured in
vitro actually extracted (presumably metabolised) acetaldehyde
and higher-order aldehydes from the support culture
media.130 Nevertheless, acetaldehyde in the headspace of cell
cultures, including cells growing in the presence of so-called
“scaﬀolds” of collagen (the three-dimensional, 3D, situation)
is proving to be a valuable indicator of the behaviour of cells
in a culture.187 In this regard, SIFT-MS has also been used to
determine the numbers of cells in a culture by quantifying
dimethyl sulphide (DMS) in the culture headspace as produced
by the cellular enzymatic reduction of dissolved dimethyl
sulphoxide (DMSO).215
More promising are the SIFT-MS studies of volatile com-
pounds emitted by bacterial cultures. These were initiated at
Keele by investigating volatiles emitted by plate cultures of the
respiratory bacterium Pseudomonas aeruginosa, PA, which colo-
nises the airways and lungs of those suﬀering from cystic fibro-
sis, CF. The remarkable discovery was that PA cultures emit
gaseous hydrogen cyanide, HCN, at headspace concentrations
corresponding to several ppmv,120,121,127,216,217 and it turns out
that this compound is a genuine biomarker of PA infection in
vivo, as is explained below in the next section. This productive
work on PA cultures has spawned an extension programme to
study volatile compound emissions from other important res-
piratory bacteria, including S. aureus, S. pneumoniae and
H. influenzae,64 and S. maltophilia and S.rhizophila strains of
the Stenotrophomonas genus,218 and the fungal pathogen Asper-
gillus fumigatus,175 the results of which are reported in a recent
series of the referenced papers. Copious amounts of volatile
compounds are released by these bacterial and fungal species
and it is anticipated that some of these compounds may be
seen at elevated levels in the exhaled breath of people whose
airways are infected with these dangerous pathogens. Exhaled
breath studies, which are in train, may reveal if any of these
volatile compounds are useful non-invasive biomarkers of res-
piratory infections.
The “holy grail” in this work would be the recognition
of single volatile biomarkers of infection, such as HCN for
PA (see below), but this is likely to be a rare occurrence
and combinations of compounds are most likely. Then ana-
lysis of data using multivariate methods,219 such as principal
component analysis, can be valuable in distinguishing
between the volatile compounds present in the exhaled
breath of healthy individuals and those with a specific
infections.
Indicators of infection and disease via breath analyses
The most important and definitive discovery at Keele, which
potentially has great value in respiratory medicine, is that
gaseous HCN is a true biomarker of PA infection. This has
been established by numerous SIFT-MS studies of many
genetically-specified strains of PA cultures grown in vitro under
planktonic and biofilm conditions. Significantly, it is seen to
be elevated in the nose-exhaled breath of patients suﬀering
from CF. Diﬀerentiating between mouth-exhaled and nose-
exhaled breath is most important, because HCN is generated
in the oral cavity of even healthy persons.220 The extensive pro-
gramme of focused research on this topic was carried out over
a decade culminating in a recent extensive multi-centre study
involving 8 hospitals in Central England involving 233 CF
patients (the “SPACE” study) that has provided essential
support for the clinical relevance of HCN as a biomarker of PA
infection in children and young adults.120 So HCN in exhaled
Fig. 7 Distributions of the ﬁve most prominent trace metabolites
present in the exhaled breath of the healthy population. The concen-
trations on the horizontal axes are shown by logarithmic scales in parts-
per-billion, ppb. The median values are given in parentheses for each
metabolite together with their geometric standard deviation, GSD.
Reproduced with permission from RSC from ref. 203.
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breath can now be exploited as a non-invasive diagnostic for
the detection and eradication of the PA bacterium in the
airways and lungs, to the advantage and support of CF
patients.
Inflammatory bowel disease (IBD) has a relatively large inci-
dence in modern populations and the current diagnostic
methods for it are either invasive or have limited sensitivity
and specificity. Thus, there is need for new non-invasive
methods for its diagnosis and the monitoring of the eﬃcacy of
treatment. Recently, interest in real-time quantification of
n-pentane in exhaled human breath has grown,221 since this
hydrocarbon is considered to be a valuable biomarker of oxi-
dative stress, lipid peroxidation and inflammation in the body,
conditions with which IBD is considered to be associated.
Thus, a pilot study of n-pentane in the exhaled breath of
patient cohorts with Crohn’s disease (CD) and ulcerative
colitis (UC) and a healthy volunteer cohort has been carried
out using a SIFT-MS Profile 3 instrument in a Prague clinic
specialising on these diseases. However, before the study
could be carried out, a detailed study of the ion chemistry
involved in the reaction of the SIFT-MS reagent ion O2
+ with
n-pentane had to be carried out to provide the essential kinetics
data required to allow accurate analysis of this hydrocarbon in
humid breath by SIFT-MS. Pentane was found to be signifi-
cantly elevated in the breath of both the CD (mean 114 ppbv)
and the UC patients (mean 84 ppbv) relative to the healthy
controls (mean 40 ppbv). The detailed results of this clinical
study, as well as the ion chemistry study, are given in a recent
paper.68 Thus, the exciting conclusion is that SIFT-MS can be
used to quantify pentane in human breath in real time (single
exhalations) avoiding sample collection and storage. This
method of analysis may ultimately become a non-invasive
screening procedure for inflammatory processes, including
IBD. Related to this area, SIFT-MS analyses and multivariate
data analysis have been used at the Silsoe Research Institute
for the diagnosis of Mycobacterium bovis in wild badgers219
based on in vitro studies of production of volatile organic com-
pounds by this bacterium.222
The search for volatile biomarkers of oesophageal and gastric
cancer
A group of surgeons and clinicians in the Department of
Surgery and Cancer at Imperial College London (leader G.B.
Hanna) have a specialist interest in oesophageal and gastric
cancer and are involved in a research programme to search for
volatile biomarkers of this disease. Their three-pronged attack
involves the analysis by SIFT-MS (and partly by GC-MS) of the
headspace of gastric content,82,86 urine85 and exhaled
breath,78,81,83,84,223 as obtained from patients cohorts with
varying stages of these cancers, together with similarly sized
cohorts of volunteers free from these diseases. Gastric content
is a complex biofluid in the stomach that has an important
role in digestive processes. It is believed that gastric content
may be a contributory factor in the development of upper
gastro-intestinal diseases. Urine is considered an ideal biofluid
for clinical investigation, because it is obtained noninvasively
and relatively large volumes are easily acquired and it surely
carries volatile and non-volatile compounds indicative of
physiological status. Exhaled breath analysis of volatile com-
pounds, as has been emphasized in this paper, has great
potential in terms of disease diagnosis and measuring physio-
logical response to treatment. These collected studies have
revealed that there are some VOCs, including phenol, methyl
phenol and hexanoic acid, that discriminate the oesophago-
gastric cancer cohort from the cancer-free control cohort, the
detailed results being given in the cited references above.
Single discriminating biomarkers are not identified; rather,
the large quantity of SIFT-MS analytical data is treated using
the familiar multivariate statistical analyses, as described in
the published papers. This group has also pioneered the using
of SIFT-MS breath analysis in the operating theatre by carrying
out on-line, real time analyses of the exhaled breath of five
anaesthetized patients during the complete perioperative
periods of laparoscopic surgery.87
The above brief reports provide just a flavour of the work
carried out in the UK (in association with the Prague group)
using SIFT-MS currently at those research centres indicated in
Fig. 1. Mention has to be made of the apparently endless
search for breath biomarkers of diabetes, and the continuous
focus on breath acetone, by a number of groups worldwide,
including some in the UK. Studies at the Open University have
shown that breath acetone concentration decreases with blood
glucose concentration in Type I diabetes mellitus patients
during hypoglycaemic clamps.136 Oﬀ-line breath acetone ana-
lysis in critical illness at Nottingham University170 has shown
that breath concentrations of acetone compare with blood
levels of this ketone. But it must be said that there are several
confounding factors that disqualify breath acetone as a reliable
biomarker of the diabetic state, as identified in a recent paper
by the Keele group.135 In a similar way, breath ammonia is
attractive as an indicator of the uraemic state, but this also
must be treated with circumspection because of confounding
factors such as oral bacterial generation of ammonia and the
well-known fact that the pH of the saliva and the blood at the
alveolar interface strongly influences the partitioning of
ammonia between the fluid and gaseous state (exhaled alveo-
lar breath in this case). This and other factors have recently
been discussed in a paper concerned with breath analysis in
chronic kidney disease and during dialysis,224 which also
describes the applications of SIFT-MS and FA-MS in renal
medicine.
Summary, concluding remarks and a forward look
The novel analytical techniques SIFT-MS and FA-MS, conceived
and developed in the UK, have been described, and a flavour
has been given of their uses and applications to ambient trace
gas analysis, the focus being on real time breath analysis and
the quantification of trace breath biomarkers in healthy volun-
teers, in disease and infection (SIFT-MS), and the on-line
determination of total body water (FA-MS). Other studies relat-
ing to physiology and medicine have been carried out at Keele
and other UK universities, in Prague and in several other
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laboratories worldwide,74,134,225–228 some being summarised in
recent review papers.4,21,28 An impressive demonstration of the
value of on-line, non-invasive analyses by SIFT-MS are the
in vitro and in vivo studies of HCN emitted by the PA bacterium
that have established exhaled HCN as a biomarker of PA infec-
tion of the lungs and airways of CF patients.120 Other similar
discoveries are likely as more scientists and enlightened phys-
icians recognise that real time breath analysis is a non-invasive
patient-friendly analytical method that can assist clinical diag-
nosis and therapeutic monitoring.
The strengths, weaknesses, opportunities and threats
(SWOT analysis) to SIFT-MS have been presented and dis-
cussed in a recent paper.59 The main limitations of SIFT-MS
relate to (i) the uncertain identification and quantification of
analyte ions, and hence of composite trace gas compounds,
due to m/z overlaps of analyte ions that can occur when analys-
ing complex mixtures, and (ii) the current limit of quantifi-
cation, which is currently at the level of ppbv for real-time
analyses when many of the trace compounds in exhaled breath
and other gaseous matrices are at sub-ppbv levels. The use of
high resolution TOF-MS can mitigate these inadequacies and
so it is an option to exploit this technology in future SIFT-MS
instruments. Further, the operation of instruments must be
made simpler such that they can be successfully operated by
technicians, scientists and health professionals (such as
nurses) without the need for specialist training and knowledge
of mass spectrometry and ions chemistry. Notwithstanding
these comments, it should be realised that there are few con-
straints to the application of SIFT-MS in fields where accuracy
and precision are not as stringent as in medicine. This is
especially so when low molecular mass compounds at rela-
tively high concentrations are to be quantified. However, it
remains true that a good understanding of the complex ion
chemistry is currently needed by the research worker for the
identification and quantification of unknown compounds
present at low concentrations; then expert assistance should
be sort.
To conclude, we have shown that the versatility of SIFT-MS
is such that this UK-developed analytical method has
been exploited profitably in many other areas of research
and enterprise, as indicated in Table 2. It is confidently
expected that SIFT-MS will be exploited to an even greater
extent when the instrumentation is made smaller, more
analyte specific and sensitive, and of lower cost so that, for
example, it can be adopted in general practitioner’s surgeries
and the clinic (for pre-screening), intensive therapy units
(for close non-invasive monitoring) and on-site in factories
(for health and safety) and even in supermarkets (for food
freshness). Innovative additions to the instrumentation
are also under active consideration at Keele and Prague,
including the exploitation of switchable drift fields and
ion separation by diﬀerential mobility in the flow tube
reactor in order to improve analyte ion (and hence analyte
compound) identification, which are intended to further
extend the versatility and utility of this ambient analytical
technique.
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